{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:59:17Z","timestamp":1790348357845,"version":"4.1.0"},"reference-count":16,"publisher":"Walter de Gruyter GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1515\/cclm-2026-1223","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:08:31Z","timestamp":1790345311000},"source":"Crossref","is-referenced-by-count":0,"title":["Multiplex microblot array as an integrated approach to ANA screening and antigen-specific profiling in systemic autoimmune rheumatic diseases"],"prefix":"10.1515","author":[{"given":"Maria","family":"Barrale","sequence":"first","affiliation":[{"name":"UOC di Patologia Clinica , Ospedale Buccheri La Ferla FBF, Referral Sicilian Regional Center for Immunoallergology , Palermo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[{"name":"Laboratorio di Patologia Clinica , Azienda Sanitaria Universitaria Integrata , Udine , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Villalta","sequence":"additional","affiliation":[{"name":"Immunology and Allergy Laboratory , Azienda Ospedaliera Friuli Occidentale, Ospedale S. Maria degli Angeli , Pordenone , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Brusca","sequence":"additional","affiliation":[{"name":"UOC di Patologia Clinica , Ospedale Buccheri La Ferla FBF, Referral Sicilian Regional Center for Immunoallergology , Palermo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026092514082548893_j_cclm-2026-1223_ref_001","doi-asserted-by":"crossref","unstructured":"Mahler, M, Meroni, PL, Bossuyt, X, Fritzler, MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J\u00a0Immunol Res 2014;2014:315179. https:\/\/doi.org\/10.1155\/2014\/315179.","DOI":"10.1155\/2014\/315179"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_002","doi-asserted-by":"crossref","unstructured":"Sciascia, S, Bizzaro, N, Meroni, PL, Dimitrios, B, Borghi, MO, Bossuyt, X, et al.. Autoantibodies testing in autoimmunity: diagnostic, prognostic and classification value. Autoimmun Rev 2023;22:103356. https:\/\/doi.org\/10.1016\/j.autrev.2023.103356.","DOI":"10.1016\/j.autrev.2023.103356"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_003","doi-asserted-by":"crossref","unstructured":"Agmon-Levin, N, Damoiseaux, J, Kallenberg, C, Sack, U, Witte, T, Herold, M, et al.. International recommendations for the assessment of autoantibodies to cellular antigens referred to as ANA. Ann Rheum Dis 2014;73:17\u201323. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203863.","DOI":"10.1136\/annrheumdis-2014-205324"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_004","doi-asserted-by":"crossref","unstructured":"Tozzoli, R, Villalta, D, Bizzaro, N. Challenges in the standardization of autoantibody testing: a comprehensive review. Clin Rev Allergy Immunol 2017;53:68\u201377. https:\/\/doi.org\/10.1007\/s12016-016-8579-y.","DOI":"10.1007\/s12016-016-8579-y"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_005","doi-asserted-by":"crossref","unstructured":"Bizzaro, N, Mazzoni, A, Carbone, T, Cinquanta, L, Villalta, D, Radice, A, et al.. Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist\u2019s perspective. Autoimmun Rev 2024;24:103604. https:\/\/doi.org\/10.1016\/j.autrev.2024.103604.","DOI":"10.1016\/j.autrev.2024.103604"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_006","doi-asserted-by":"crossref","unstructured":"Damoiseaux, JG, Tervaert, JW. From ANA to ENA: how to proceed? Autoimmun Rev 2006;5:10\u201317. https:\/\/doi.org\/10.1016\/j.autrev.2005.05.007.","DOI":"10.1016\/j.autrev.2005.05.007"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_007","doi-asserted-by":"crossref","unstructured":"Bizzaro, N, Villalta, D, Bini, V, Migliorini, P, Franceschini, F, Piantoni, S, et al.. Multiparametric autoantibody analysis: a new paradigm for the\u00a0diagnosis of connective tissue diseases. Arthritis Res Ther 2022;24:278. https:\/\/doi.org\/10.1186\/s13075-022-02980-x.","DOI":"10.1186\/s13075-022-02980-x"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_008","doi-asserted-by":"crossref","unstructured":"Fritzler, MJ, Choi, MY. Antinuclear antibody testing: gold standard revisited. J\u00a0Appl Lab Med 2022;7:357\u201361. https:\/\/doi.org\/10.1093\/jalm\/jfab129.","DOI":"10.1093\/jalm\/jfab129"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_009","doi-asserted-by":"crossref","unstructured":"Cafaro, G, Bartoloni, E, Baldini, C, Franceschini, F, Riccieri, V, Fioravanti, A, et al.. Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters. RMD Open 2023;9:e003365. https:\/\/doi.org\/10.1136\/rmdopen-2023-003365.","DOI":"10.1136\/rmdopen-2023-003365"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_010","doi-asserted-by":"crossref","unstructured":"Infantino, M, Carbone, T, Patel, D, Sargur, R, Stanley, C, Bhayat-Cammack, A, et al.. Harmonization of anti-nuclear antibody testing (ANA) by indirect immunofluorescence assay: results from ten years of UK NEQAS external quality assessment. Clin Chim Acta 2025;567:120088. https:\/\/doi.org\/10.1016\/j.cca.2024.120088.","DOI":"10.1016\/j.cca.2024.120088"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_011","doi-asserted-by":"crossref","unstructured":"Vercammen, M, Bonroy, C, Broeders, S, Chan, EKL, Bizzaro, N, Bogdanos, DP, et al.. Analytical aspects of the antinuclear antibody test by HEp-2 indirect immunofluorescence: EFLM report on an international survey. Clin Chem Lab Med 2023;61:1199\u2013208. https:\/\/doi.org\/10.1515\/cclm-2023-0210.","DOI":"10.1515\/cclm-2023-0210"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_012","doi-asserted-by":"crossref","unstructured":"Infantino, M, Pavia, F, Grossi, V, Lari, B, Benucci, M, Li Gobbi, F, et al.. Evaluation of a new multiparametric microdot array-based immunoassay panel for systemic autoimmune disease diagnosis. J\u00a0Pers Med 2024;14:607. https:\/\/doi.org\/10.3390\/jpm14060607.","DOI":"10.3390\/jpm14060607"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_013","doi-asserted-by":"crossref","unstructured":"Bizzaro, N, Brusca, I, Previtali, G, Alessio, MG, Daves, M, Platzgummer, S, et al.. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases. Autoimmun Rev 2018;17:541\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2017.12.007.","DOI":"10.1016\/j.autrev.2017.12.007"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_014","doi-asserted-by":"crossref","unstructured":"Buzzulini, F, Villalta, D, Previtali, G, Alessio, MG, Cafaro, G, Bartoloni, E, et al.. Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases. Clin Exp Rheumatol 2025;43:1622\u20138.","DOI":"10.55563\/clinexprheumatol\/h03g16"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_015","doi-asserted-by":"crossref","unstructured":"Irure-Ventura, J, L\u00f3pez-Hoyos, M. The past, present, and future in antinuclear antibodies (ANA). Diagnostics (Basel) 2022;12:647. https:\/\/doi.org\/10.3390\/diagnostics12030647.","DOI":"10.3390\/diagnostics12030647"},{"key":"2026092514082548893_j_cclm-2026-1223_ref_016","doi-asserted-by":"crossref","unstructured":"Nikolic, RPA, Ben-Chetrit, E, Fritzler, MJ, Buhler, KA, Shokravi, A, Barreth, NH, et al.. International expert consensus recommendations on standardised nomenclature of SSA\/Ro (TROVE2\/Ro60 and TRIM21\/Ro52) autoantibodies in autoimmune diseases. Ann Rheum Dis 2026;14:S0003-4967(26)00228 in press. https:\/\/doi.org\/10.1016\/j.ard.2026.04.007.","DOI":"10.1016\/j.ard.2026.04.007"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1223\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:08:37Z","timestamp":1790345317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1223\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":16,"alternative-id":["10.1515\/cclm-2026-1223"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-1223","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}